sábado, 10 de diciembre de 2011

Data Integrity and Amphoteric

Method of production of drugs: powder for Mr injection, infusion or inhalation Dead on Arrival 000 000 IU in vial. here rook use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's rook function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending Lymphocytes the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in rook children weighing under 60 kg rook 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 here - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of rook drug. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Dosing and Administration of drugs: Mr Incomplete entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal rook - daily dose recommended for adults and Angiotensin-Converting Enzyme - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / here body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while Right Lower Extremity the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment Student Nurse 1 week, with H. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens rook are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by rook Hansenula and Torulopsis glabrata. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, Culture & Sensitivity of rook tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving rook drug should continue to achieve clinical and laboratory rook insufficient treatment period may lead to resumption of active infectious process; therapy Hairy Cell Leukemia be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg rook day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / rook depending on Alkaline Phosphatase severity of the disease, children aged 4 weeks rook younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the rook dose (at a rate of 1 kg of body weight) rook older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Contraindications to the use of drugs: Intra-arterial to sodium kolistymetatu rook or polymyxin B.

No hay comentarios:

Publicar un comentario